
Keywords: گیرنده فاکتور رشد اپیدرمال; JCOG; Japan Clinical Oncology Group; SCLC; small cell lung cancer; ED; extensive disease; OS; overall survival; WJOG; West Japan Oncology Group; NSCLC; non-small-cell lung cancer; EGFR; epidermal growth factor receptor; PFS; progression-free survival; TKI